Locoregionally Advanced Penile Cancer clinical trials

Explore recruiting locoregionally advanced penile cancer clinical trials.

Recruiting locoregionally advanced penile cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locoregionally Advanced Penile Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 clinical study to assess efficacy of induction carboplatin/paclitaxel + pembrolizumab for locoregionally advanced penile cancer: PRIAM

Netherlands, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Locoregionally Advanced Penile Cancer trials by city

Locoregionally Advanced Penile Cancer in Toronto Locoregionally Advanced Penile Cancer in Vancouver Locoregionally Advanced Penile Cancer in Montreal Locoregionally Advanced Penile Cancer in Calgary Locoregionally Advanced Penile Cancer in Edmonton Locoregionally Advanced Penile Cancer in Ottawa Locoregionally Advanced Penile Cancer in Winnipeg Locoregionally Advanced Penile Cancer in Quebec City Locoregionally Advanced Penile Cancer in Hamilton Locoregionally Advanced Penile Cancer in Kitchener Locoregionally Advanced Penile Cancer in London Locoregionally Advanced Penile Cancer in Halifax Locoregionally Advanced Penile Cancer in New York Locoregionally Advanced Penile Cancer in Los Angeles Locoregionally Advanced Penile Cancer in Chicago Locoregionally Advanced Penile Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease